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Childhood chronic pancreatitis is a rare disorder, which can lead to a chronically debilitating condition.
The etiology of recurrent hereditary pancreatitis, which previously was classiﬁed as idiopathic, has now
been attributed in certain cases to speciﬁc genetic mutations including abnormalities in the PRSS gene.
We describe here the use of total pancreatectomy and autoislet transplant in a 5-year-old with chronic
pancreatitis. This represents the youngest patient undergoing the procedure at our institution. The early
successful outcomes for this patient, both of symptom relief and glycemic control are detailed.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Pancreatitis in childhood is relatively rarewhen compared to the described for chronic pancreatitis [2] and speciﬁcally genetic
adult population and its etiology is also different than the adult
counterpart. Chronic recurrent pancreatitis can result from trauma,
hereditary, systemic disease, or anatomic etiologies. Several gene
mutations have been implicated in hereditary or idiopathic
pancreatitis including PRSS, CFTR, and SPNK [1].
Surgical intervention for chronic pancreatitis is typically
reserved for refractory symptoms unresponsive to medical or
endoscopic management, or in the setting of suspected or
conﬁrmed malignancy. Surgical procedures for chronic pancreatitis
include drainage, resection, or combined procedures.
Total pancreatectomy for chronic pancreatitis is typically be
reserved for rare situations with pre-existing diabetes since the
total impact of the loss of endocrine function may be limited. The
loss of counter-regulatory mechanisms from this procedure poses
signiﬁcant metabolic implications and glycemic control can be
challenging, even life threatening, for these patients. Treatment
with pancreatectomy combined with autoislet transplant has been: þ1 780 407 8259.
Inc. This is an open access article upancreatitis in adult patients [3]. In children, total pancreatectomy
with autoislet transplant has been demonstrated to provide pain
relief and improved quality of life for children aged 5e19 years old
in the setting of failure of medical and endoscopic management [4].
Chinnakotla et al. have speciﬁcally described the indications for
total pancreatectomy and autoislet transplant used at their insti-
tution [4]. The ability to predict successful islet yield in a patient
with chronic pancreatitis has also been described [5,6].
Case series examined the application and islet yield of the pro-
cedure for school aged and adolescents with chronic pancreatitis
[4,5,7]; however, application in a pre-school aged (that is less than 6
years old) is more limited. We describe here our experience with
our youngest patient with chronic pancreatitis undergoing total
pancreatectomy and autoislet transplant.
1. Case report
1.1. Clinical history
A 5-year-old boy initially presented with recurrent bouts of
acute abdominal pain secondary to episodic acute pancreatitisnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Total Pancreatectomy. Total pancreatectomy was performed with modiﬁcation to minimize warm ischemic time to the pancreas. Dissection of the pancreas including isolation
of the splenic artery, splenic vein, portal vein was achieved (A). Both the ventral and dorsal pancreatic duct were cannulated on the back table, and the duodenum and spleen
removed from the pancreas in the islet laboratory (B).
Table 1
Perioperative glycemic proﬁle.
Pre-op Post-op 8 mo follow-up
Glucose (random) mmol/L 3.4 5.4 4.4
HbA1c (%) N/A N/A 5.6s
c-Peptide (mmol/L) 0.23
Insulin (pmol/L) 18 14.9
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These episodes were very disruptive resulting in hospitalization for
supportive management including narcotic analgesic use. The pa-
tient had not required endoscopic management. The patient was
therefore thought to be at signiﬁcant risk of both nutritional and
developmental sequelae. Subsequent genetic testing conﬁrmed an
underlying PRSS1 mutation.
After multidisciplinary consultation, the patient was offered
total pancreatectomy given the likely pancreatic burnout with
progression to diabetes and the concerning long-term risks of
developing pancreatic cancer. Endocrine replacement with islet
autoislet transplantation was discussed and consent from the
child’s parents was obtained.
1.2. Pancreatectomy and autoislet transplantation
Total pancreatectomy, with en bloc duodenectomy and sple-
nectomy was performed though transverse laparotomy (Fig. 1). The
patient weighed 19.1 kg andmeasured 107 cm tall at the time of the
procedure. Pancreatic specimen was placed in histidine-trypto-
phan-ketoglutarate (HTK) cold preservations solution on the back
table, where the pancreatic duct was cannulated. The organ was
then packaged for transportation to the islet isolation laboratory.
Islet isolationwas performed without puriﬁcation using method
previously described [8]. The 32.2 g pancreas was digested for
17 min. Non-puriﬁed product of 6 cc tissue contained 196,275 islet
equivalents (IEQ) (or 10,276 IEQ/kg). The estimated viability was
96.5% and purity was 20%. Total processing time was 91 min.
Heparin at a dose of 70 units/kg body weight was added into the
islet preparation. Gravity infusion of the islets into the portal vein
was performed and portal pressure was measured at 10 mm Hg
prior to infusion and 17 mm Hg after. Biliary and enteric recon-
struction was achieved with a roux-en-Y choledochojejunostomy
and gastrojejunostomy.
1.3. Post-operative and early outcomes
The child was maintained on 300 units/hour of IV unfractionated
heparin for the ﬁrst two post-operative days. Post-operatively, the
patient was advanced to a full diet. The patient did experience
gastroparesis while in hospital that was investigated with both an
ultrasound and computed tomography imaging of the abdomen and
pelvis. Neither demonstrated evidence for obstruction or post-sur-
gery related pathology. The portal vein remained patent on imaging.
Domperidone was used to treat the gastroparesis, with good effect
and return to normal bowel function.The patient’s early post-operative random glucose levels
remained between 5 and 6 mmol/L, and he never required in-
sulin. Serum insulin and c-peptide levels remained positive
(Table 1).
At 8-month post-operatively, the patient has remained pain free
and had not required any hospitalization. Islet graft function
appeared appropriate with random glucose 4.4 and Hgb A1c of
5.6%. He continues to receive pancreatic exocrine replacement
therapy without symptoms of either diarrhea or malabsorption. He
will be followed clinically with repeat blood work twice annually.2. Discussion
Total pancreatectomy and autoislet transplant is a treatment
option for certain cases of pancreatitis. The use of this in the
adolescent population and even school aged child has been
described. We present here early success in relief of symptoms and
glycemic control when this treatment was offered to a pre-school
child debilitated by hereditary pancreatitis.
Case series have demonstrated success of this procedure in
children, even demonstrating that younger agewas associated with
higher rates of insulin independence following the procedure [4],
possibly in part related to treatment before islet cell burnout from
recurrent chronic pancreatitis.
The current report demonstrates that the procedure can be
performed with good short-term outcomes and safety proﬁle in
childhood. The expansion of this procedure to an even younger age
group (pre-school aged), we believe requires special attention to
safety and outcome of the procedure speciﬁcally in this cohort.
In addition to the morbidities associated with a major abdom-
inal surgery, there is the concern for portal hypertension resulting
from infusion of a non-puriﬁed islet preparation directly into the
portal circulation. Intra-operative portal pressure monitoring al-
lows for dynamic measurement during the islet transplant pro-
cedure. With regards to portal vein thrombosis, consideration must
be given to the balancing the risk of systemic heparinization to
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(0%) [4] undergoing islet transplantation.
Hereditary pancreatitis related to PRSS1 mutations carries an
increased risk of life time development of pancreatic adenocarci-
noma [10], which is inﬂated over that seen in chronic pancreatitis
due to other etiologies. Pancreatic resection is thought to be pro-
tective of cancer development. Available data on pediatric patients
with PRSS mutations undergoing total pancreatectomy with auto-
islet transplantation demonstrate that none have developed ma-
lignancy [4].
Though case series, a deﬁnition of the indications and contra-
indications to total pancreatectomy and islet transplantation for
hereditary pancreatitis in childhood as well as parameters for the
timing for the procedure has been proposed [4]. Expanding this
procedure to an even younger aged cohort may provide beneﬁt to
early onset chronic pancreatitis in pre-school child.
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